scholarly journals A Complex Microbial Interplay Underlies Recurrent Vulvovaginal Candidiasis Pathobiology

mSystems ◽  
2021 ◽  
Author(s):  
Nicolas Papon ◽  
Patrick Van Dijck
Keyword(s):  
Women’S Health ◽  
Women's Health ◽  
Vulvovaginal Candidiasis ◽  
Recent Issue ◽  
Recurrent Vulvovaginal Candidiasis

While extremely prevalent, painful, and difficult to treat, vulvovaginal candidiasis remains largely understudied in the field of women’s health. In a recent issue of mSystems , McKloud et al. (E.

scholarly journals Recurrent Vulvovaginal Candidiasis: a Dynamic Interkingdom Biofilm Disease of Candida and Lactobacillus

mSystems ◽  
2021 ◽  
Author(s):  
Emily McKloud ◽  
Christopher Delaney ◽  
Leighann Sherry ◽  
Ryan Kean ◽  
Shanice Williams ◽  
...  
Keyword(s):  
Women’S Health ◽  
Women's Health ◽  
Treatment Options ◽  
Vulvovaginal Candidiasis ◽  
Recurrent Vulvovaginal Candidiasis ◽  
Prevention And Treatment ◽  
Significant Burden

RVVC is a significant burden, both economically and for women's health, but its prevalence is poorly documented globally due to the levels of self-treatment. Identifying triggers for development and recurrence of VVC and the pathogenesis of the microbes involved could considerably improve prevention and treatment options for women with recurrent, azole-resistant cases.

scholarly journals Sertaconazole in the treatment of vulvovaginal candidiasis

2019 ◽  
pp. 94-98 ◽  
Author(s):  
Z. N. Efendieva
Keyword(s):  
Drug Resistance ◽  
Women’S Health ◽  
Women's Health ◽  
Vulvovaginal Candidiasis ◽  
Important Task ◽  
Safety And Efficacy

Vulvovaginal candidiasis today is one of the most pressing problems in the field of women’s health. However, the prevalence of Candida with formed drug resistance to fluconazole significantly complicates the treatment of this disease. Thus, the evaluation of the safety and efficacy of other antimycotic drugs becomes an important task in the fight against recurrent genital candidiasis. The article presents the data of international and domestic studies on the possibilities of using sertaconazole in the therapy of vulvovaginal candidiasis.

Sign in / Sign up

Export Citation Format

Share Document